Fodstad O - Search Results

1

TP53 allele loss, mutations and expression in malignant melanoma.

Flørenes VA, Oyjord T, Holm R, Skrede M, Børresen AL, Nesland JM, Fodstad O. Flørenes VA, et al. Among authors: fodstad o. Br J Cancer. 1994 Feb;69(2):253-9. doi: 10.1038/bjc.1994.48. Br J Cancer. 1994. PMID: 7905277 Free PMC article.

2

Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.

Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA. Maelandsmo GM, et al. Among authors: fodstad o. Clin Cancer Res. 2003 Aug 15;9(9):3383-8. Clin Cancer Res. 2003. PMID: 12960126

3

MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.

Flørenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O, Fodstad O. Flørenes VA, et al. Among authors: fodstad o. J Natl Cancer Inst. 1994 Sep 7;86(17):1297-302. doi: 10.1093/jnci/86.17.1297. J Natl Cancer Inst. 1994. PMID: 8064888

4

Expression of the neuroectodermal intermediate filament nestin in human melanomas.

Flørenes VA, Holm R, Myklebost O, Lendahl U, Fodstad O. Flørenes VA, et al. Among authors: fodstad o. Cancer Res. 1994 Jan 15;54(2):354-6. Cancer Res. 1994. PMID: 8275467

5

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.

Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O. Maelandsmo GM, et al. Among authors: fodstad o. Br J Cancer. 1996 Apr;73(8):909-16. doi: 10.1038/bjc.1996.181. Br J Cancer. 1996. PMID: 8611425 Free PMC article.

6

Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions.

Maelandsmo GM, Holm R, Fodstad O, Kerbel RS, Flørenes VA. Maelandsmo GM, et al. Among authors: fodstad o. Am J Pathol. 1996 Dec;149(6):1813-22. Am J Pathol. 1996. PMID: 8952518 Free PMC article.

7

Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme.

Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Flørenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ, Fodstad O. Maelandsmo GM, et al. Among authors: fodstad o. Cancer Res. 1996 Dec 1;56(23):5490-8. Cancer Res. 1996. PMID: 8968106

8

Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma.

Maelandsmo GM, Flørenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O. Maelandsmo GM, et al. Among authors: fodstad o. Int J Cancer. 1997 Aug 22;74(4):464-9. doi: 10.1002/(sici)1097-0215(19970822)74:4<464::aid-ijc19>3.0.co;2-9. Int J Cancer. 1997. PMID: 9291441

9

Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies.

Pedersen KB, Nesland JM, Fodstad Ø, Maelandsmo GM. Pedersen KB, et al. Among authors: fodstad o. Br J Cancer. 2002 Nov 18;87(11):1281-6. doi: 10.1038/sj.bjc.6600624. Br J Cancer. 2002. PMID: 12439718 Free PMC article.

10

Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.

Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O. Flørenes VA, et al. Among authors: fodstad o. Cancer Res. 1992 Nov 1;52(21):6088-91. Cancer Res. 1992. PMID: 1356624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters